TY - GEN A1 - Knauthe, Nadja A1 - Fieber, Vera A1 - Glausch, Melanie A1 - Geissler, Mark Enrik A1 - Dallal, Anna A1 - Doll, Konrad A1 - Meister, Lisa A1 - Tallarek, Marie A1 - Weigmann-Faßbender, Sandra A1 - Giesemann, Nadine A1 - Hofbauer, Christine A1 - Bornhäuser, Martin A1 - Letsch, Anne A1 - Ratjen, Ilka A1 - Spallek, Jacob A1 - Stölzel, Friederike ED - Büttner, Reinhard T1 - „Aktiv leben mit Krebs“: acceptance and effect of a lowthreshold information on health behavior for cancer patients T2 - Oncology Research and Treatment 2024 : 36. Deutscher Krebskongress. Fortschritt gemeinsam gestalten, 21.–24. Februar 2024, Berlin: ABSTRACTS N2 - Background: In Germany, more than 4.65 million people are currently living with a cancer diagnosis. Patients can benefit from a healthy lifestyle both during and after therapy. In order to provide patients with practical and scientifically based information on health behavior, the authors developed “Aktiv leben mit Krebs” (ALMIK) using participatory program planning. Methods: A non-blinded randomized controlled trial with intervention (IG) and wait list control group (WCG) was conducted at NCT/UCC Dresden and UCCSH in Kiel in 2022/2023 with a convenience sample of n=227 patients during and after therapy (65.7 years ± 11.7, 54.2% male). IG and WCG received a questionnaire at baseline and after 1 month. IG received the ALMIK brochure and a link to the website with videos. Changes in health literacy (HLS-EU Q) and acceptance were assessed. Result: Acceptance of ALMIK in IG was high: 94.1% of all n=109 patients in the IG reported having used the brochure. 40.4% had visited the website. Videos were used by 36.7%. Almost all patients rated the brochure as understandable (97.8%), relevant (90.3%) and clearly presented (98.9%). Patients also rated the website as well-structured (95.6%) and attractively designed (97.6%), and the videos as understandable (93.0%) and relevant (79.1%). Overall, 97.8% were satisfied with the program and 98.9% would recommend it to others. Patients of IG did not achieve higher HLS-score in comparison to WCG (p=0.75). Discussion: The brochure was used by many patients and was very well accepted. The website and videos were used less frequently, but overall by more than one-third of patients, who were also satisfied with them. Health literacy was not increased by ALMIK, which may be due to the low intervention strength. Conclusion: The high number of participants who used ALMIK indicates a high need for health behavior information for cancer patients. Patient involvement has proven to be an important component in creating well accepted program materials Y1 - 2024 UR - https://karger.com/ort/article-pdf/47/Suppl.%201/7/4169504/000535363.pdf U6 - https://doi.org/10.1159/000535363 SN - 2296-5262 SN - 2296-5270 VL - 47 IS - 1 SP - 216 ER -